A new integrated program aims to standardize epigenetic assays and extend research on epigenetic therapies in immuno‐oncology, promising significant advancements in both medical and environmental fields. This initiative leverages insights from DNA methylation and histone modifications to boost precision medicine and enhance biodiversity monitoring, while addressing public concerns regarding mood-related applications. With a focus on validating findings within complex ecosystems, the program seeks to manage expectations around epigenetic outcomes in both health and environmental resilience.
“Crohn’s is a type of inflammatory bowel disease characterized by severe irritation in the digestive tract.”
“The Institute was recently awarded a grant from The Leona M. and Harry B. Helmsley Charitable Trust for a project Dr. Laird will lead to investigate possible links between Crohn’s and epigenetics.”
“Dr. Peter W. Laird hopes to change that.”
“How Epigenetics Could Revolutionize ADHD Care. Could epigenetics research revolutionize our approach to ADHD?”
“As scientists uncover and better understand the epigenetic markers associated with ADHD, the hope is that this information will contribute to the development of new precision medicine toolkits for better detection, monitoring, and treatment formulation.”
“One study found that epigenetic patterns at birth associate prospectively with the severity of ADHD symptoms in mid to late childhood.”
“While we’ve attempted to specify presentations of ADHD — predominantly inattentive, predominantly hyperactive/impulsive, and combined presentation — we are simply not yet good at separating and understanding why individuals with ADHD follow such different courses and clinical presentations.”
“Today’s ADHD medications work well for many patients, but a sizable minority — up to 35% — don’t respond to them at all.”
“In the future, epigenetic profiling may help clinicians predict and monitor therapeutic responses to different types and classes of medications and with greater specificity.”
“Variation in an Iron Metabolism Gene Moderates the Association Between Blood Lead Levels and Attention-Deficit/Hyperactivity Disorder in Children.”
“Methylation consists of a covalent modification of DNA in which a methyl group (CH3) is transferred from S-adenosylmethionine to the carbon 5 of a cytosine (5mC) that typically precedes a guanine (CpG dinucleotide).”
“Histone modifications act in the regulation of gene transcription, as they interfere with chromatin condensation, which is directly related to whether DNA regions are accessible or inaccessible to the transcriptional machinery.”